Southwest Center on Aging

11/19/2025

Heath Benefits of Exercise.

11/18/2025

Why soda is so addictive, and how it affects health?

11/18/2025

A decades-long Swedish study revealed a powerful link between physical fitness and brain health in women. Those who were highly fit in midlife were nearly 90% less likely to develop dementia later on. Just 5% of the fittest participants went on to be diagnosed, compared to up to 32% among less active peers.

Even when dementia did occur in the fit group, it was delayed by roughly a decade—highlighting the strong protective effect of sustained cardiovascular health. The research adds to growing evidence that staying active in midlife isn’t just good for the body—it’s one of the most effective long-term investments in cognitive well-being.

11/15/2025

Does coffee reduce atrial fibrillation recurrence?

11/14/2025

Chronic Kidney Disease (CKD): A global Crisis.

11/13/2025

Shingles vaccine and dementia. #ɢᴇᴛᴠᴀᴄᴄɪɴᴀᴛᴇᴅ

11/12/2025

This week,, the FDA announced that it's removing the "black box" warning—the strongest safety alert that can appear on a drug label—from menopausal hormone therapy (MHT, formerly known as HRT). This ends 22 years of overly broad cautions that scared millions of women away from treatment.

The original 2002 warning came from a flawed study of women averaging 63 years old (well past menopause). Newer evidence suggests that timing matters: MHT initiated within 10 years of menopause appears to be much safer. Not only can it relieve symptoms like hot flashes, sleep difficulties, and genitourinary problems, but it also has potential benefits for heart, bone, and brain health.

The American College of Obstetricians and Gynecologists (ACOG) commended the change, noting they've long advocated for removing barriers to treatment—especially for low-dose vaginal estrogen. As ACOG's president stated, this puts "shared decision-making back in the hands of patients and their trusted clinicians."

Some context: After the 2002 warning, MHT prescriptions dropped 70%. While the process for this reversal has drawn criticism (the FDA used a special panel rather than standard advisory committees), the science supports a more nuanced approach.

Bottom line: This change removes an unnecessary barrier that kept effective treatment from women who could benefit. The updated labels will allow patients and doctors to have honest conversations about individual risks and benefits, not be scared off by warnings based on outdated data from women who started MHT in their 70s.

https://www.acog.org/news/news-releases/2025/11/acog-president-says-label-change-on-estrogen-will-increase-access-to-hormone-therapy
https://www.hhs.gov/press-room/hhs-advances-womens-health-removes-misleading-fda-warnings-hormone-replacement-therapy.html

11/11/2025

This Veteran’s Day, we pause to honor the men and women whose courage and sacrifice have made our freedom possible.
Their discipline, resilience, and strength remind us that freedom isn’t simply granted, it’s earned and protected every day.

11/11/2025

Are you loosing concentration and focus?
It could be ADHD (Attention Deficit Hyperactivity Disorder).

11/10/2025

11/08/2025

Maybe eggs are not the enemy.

11/07/2025

Listen to music and decrease your risk of dementia?